COC(=O)c1c(C(=O)OC)c(-c2cccc(F)c2)n2c1CS(=O)(=O)C2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?